A detailed history of Farther Finance Advisors, LLC transactions in Zai Lab LTD stock. As of the latest transaction made, Farther Finance Advisors, LLC holds 134 shares of ZLAB stock, worth $4,211. This represents 0.0% of its overall portfolio holdings.

Number of Shares
134
Previous 309 56.63%
Holding current value
$4,211
Previous $5.34 Million 39.45%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

SELL
$16.25 - $24.14 $2,843 - $4,224
-175 Reduced 56.63%
134 $3.24 Million
Q2 2024

Jul 31, 2024

BUY
$13.72 - $21.55 $3,676 - $5,775
268 Added 653.66%
309 $5.34 Million
Q1 2024

May 13, 2024

BUY
$15.95 - $26.8 $79 - $134
5 Added 13.89%
41 $686,000
Q4 2023

Feb 14, 2024

BUY
$22.97 - $30.58 $826 - $1,100
36 New
36 $984,000

Others Institutions Holding ZLAB

About Zai Lab Ltd


  • Ticker ZLAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,908,704
  • Market Cap $3.08B
  • Description
  • Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...
More about ZLAB
Track This Portfolio

Track Farther Finance Advisors, LLC Portfolio

Follow Farther Finance Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Farther Finance Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Farther Finance Advisors, LLC with notifications on news.